EPICS Therapeutics
PrivateLast Round
VC Round
Sep 22, 2025
Total Funding Raised
$37.54M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
EPICS Therapeutics is a biotechnology company that develops small molecule drugs targeting RNA epigenetic mechanisms for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EPICS Therapeutics Comparables
Compare EPICS Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| STORM Therapeutics | 90% | |
| Accent Therapeutics | 87% | |
| 858 Therapeutics | 79% |
EPICS Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 22, 2025 | ||||
| Series A Extension | Oct 18, 2024 | ||||
| Series A | Dec 31, 2018 | ||||
| Seed | May 24, 2018 |
EPICS Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | VC Round, Series A, Series A Extension |
| Newton Biocapital | Series A, Seed, VC Round, Series A Extension |
| Fund+ | VC Round, Series A, Series A Extension |
| Société Régionale d'Investissement de Wallonie | Seed, Series A |
| Investsud | Seed |
| Wallonie Entreprendre | Seed, VC Round, Series A Extension |
| Theodorus | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 43% MoM, reaching 720.
- Oct 18, 2024
$13M round led by Newton Biocapital.
EPICS Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EPICS Therapeutics's valuation, stock price, and market status.
Is EPICS Therapeutics a public or private company?
EPICS Therapeutics is a private company.
What is the current stock price of EPICS Therapeutics?
EPICS Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is EPICS Therapeutics worth (valuation)?
Valuation information for EPICS Therapeutics is not publicly available.
Can I buy EPICS Therapeutics stock?
EPICS Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was EPICS Therapeutics's last funding round?
EPICS Therapeutics's most recent funding round was Early Funding on September 22, 2025.
Who are the main investors in EPICS Therapeutics?
Key investors in EPICS Therapeutics include Federal Holding and Investment Company, Fund+, Société Régionale d'Investissement de Wallonie, Investsud, Wallonie Entreprendre.
Will EPICS Therapeutics IPO soon?
No public IPO plans have been announced for EPICS Therapeutics.
How can I track EPICS Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EPICS Therapeutics's secondary market activity and sign up for updates.